Victoria P Werth, Roy Fleischmann, Michael Robern, Zahi Touma, Iyabode Tiamiyu, Oksana Gurtovaya, Alena Pechonkina, Afsaneh Mozaffarian, Bryan Downie, Franziska Matzkies, Daniel Wallace, Filgotinib or Lanraplenib in Moderate to Severe Cutaneous Lupus Erythematosus: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study, Rheumatology, 2021;, keab685, https://doi.org/10.1093/rheumatology/keab685